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Abstract
Background: Calcium sulphate (CS) has been used in bone grafting since the 1800s. It has not replaced autograft
as the gold standard, however, since its dissolution occurs rapidly in bodily fluids, meaning that the material cannot
support long-term bone growth. Here, the polymer poly (ether ether ketone) (PEEK) was used to slow dissolution in
in vitro physiological environments and augment the mechanical properties of the material.
Methods: PEEK/CS specimens were fabricated by combining powders of PEEK and CS with water, resulting in a
hardening paste. To enhance physical interactions between phases, cylindrical specimens were heat-treated to melt
and fuse the PEEK. Following analysis of physical and chemical interactions by SEM and FT-IR respectively, dynamic
ageing in PBS and compression testing was undertaken to measure how the PEEK influenced the mechanical
properties of the final parts. Changes in structure and chemistry were determined using helium pycnometry, SEM
and analysis of powder XRD patterns.
Results: Powders of PEEK and CS hemihydrate (CSH) (CaSO4.0.5H2O) were combined with PEEK at 0 wt%, 2.5 wt%, 20
wt%, 40 wt% and 80 wt% and at a P:L ratio of 0.85 g/mL. The subsequently hardened structures were heat-treated,
which initiated the melting of PEEK and dehydration of CSD (CaSO4.2H2O) to the CS anhydrite (CSA) (CaSO4) phase,
which changed colour and apparent volume. FT-IR and SEM analysis revealed heat treatment of PEEK/CS specimens
facilitated both physical and chemical interactions between phases. Over a period of 21 days of ageing in PBS, the
hydration of CS was determined by XRD and improved specimen longevity at all levels of PEEK wt% loading was
measured compared with the control. Importantly, increasing PEEK wt% loading resulted in a marked increase in the
mechanical properties of PEEK/CS specimens in terms of both compressive strength and modulus.
Conclusions: Reinforcement of CS with PEEK significantly enhanced in vitro dissolution resistance, in addition to
enhancing mechanical properties. This composite therefore has significant future potential as a bone graft
replacement.
Keywords: Bone graft, Biomaterial, Calcium sulphate, PEEK
Background
Bone graft materials should support the attachment and
proliferation of osteoblast cells, and facilitate the depos-
ition of new hard tissue in bone defects [1]. Ideally, these
materials allow for the conduction of new mineral de-
position and demonstrate good integration with adjacent
bony tissues [2]. Increasingly, synthetic minerals are
chosen over bone harvested from patient’s own body.
This is despite autologous bone graft being considered
the “gold standard” graft material, due to the low risk of
immunological rejection associated with its use [3, 4].
The reasons for alternative bone graft selection are that
the volume of autologous bone is limited and requires
additional surgery to obtain, which poses further risk to
a patient in terms of contracting an infection, blood loss
and experiencing unnecessary discomfort thereafter [4].
In addition, allograft tissue suffers drawbacks in terms of
disease transmission and possible rejection [4].* Correspondence: L.M.Grover@bham.ac.uk
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Synthetic bioceramic materials, particularly calcium




2−) and silicate (SiO4
4−) are proven examples
of minerals that are able to regenerate areas of removed
or diseased hard tissue [5–11]. Moreover, these materials
can be employed directly and are available in a variety of
forms that includes granules and injectable cementitious
pastes, allowing surgeons to select the most appropriate
product on a case-by-case basis.
The first ceramic material in widespread use for skel-
etal regeneration was calcium sulphate (CS). The ability
of CS to be set in situ or applied directed as granules
means that the material can be delivered in a number of
ways [12, 13]. CS hemihydrate (CSH) (CaSO4.0.5H2O)
and CS anhydrite (CSA) (CaSO4) forms cement when
mixed with water, which hardens to form CS dihydrate
(CSD) (CaSO4.2H2O) (Equation 1 and 2). The inter-
action between phases is reversible, as the water of
crystallization can be removed by heating CSD
(CaSO4.2H2O) (Equation 3 and 4). CS was first used at
the end of the 19th century to provide a fully resorbable
osteoconductive scaffold capable of facilitating new bone
formation in the diseased tissue of human tuberculosis
sufferers [9]. CS is able to facilitate cavity healing in-
curred from curettage of bone cysts, as well as being
used successfully to augment osteoportic bone to allow
for mechanical fixation of pedicle screws [10, 11, 14].
CaSO4:0:5H2Oþ 1:5H2O→CaSO4:2H2O
þ heat ð1Þ
CaSO4 þ 2H2O→CaSO4:2H2O þ heat ð2Þ
CaSO4:2H2O þ heat→CaSO4:0:5H2O
þ 1:5H2O ð3Þ
CaSO4:2H2O þ heat→CaSO4 þ 2H2O ð4Þ
Whilst resorbable graft materials are desirable, CS has
been limited in its application since it undergoes rapid
dissolution by hydrolytically driven degradation when
placed in the body [15–17]. In contrast, biominerals such
as hydroxyapatite (Ca5(PO4)3OH) (HA) are considerably
less soluble in physiological conditions, offering a more
stable network to support bone formation [18, 19]. Given
that newly forming bone may take several weeks to fill a
defect, these more stable calcium phosphate ceramics are
favoured over CS for defect augmentation [6, 13].
Strategies to improve the degradation behavior of CS
include combination with less soluble mineral phases
and additives to from composites that possess enhanced
properties. In combination with β-tricalcium phosphate
(β-TCP) CS still undergoes dissolution but the calcium
phosphate mineral is able to remain at the implant site
for a longer period [20]. Composites containing CS can
be modified to adjust degradation rate whilst dampening
the production of acidic dissolution products [17, 21].
The addition of other phases can also augment the
mechanical properties of the graft materials, with previ-
ous work showing that HA addition to CS may signifi-
cantly enhance mechanical properties [22]. Attempts to
combine CS with carboxymethylcellulose and hyaluro-
nan improved mechanical properties of the material but
at a cost of faster dissolution [23].
It was postulated that combination of CS with an en-
gineering polymer phase could allow for tunable hydro-
lytic degradation and mechanical attributes without
trade-off, extending the capability of CS as a bone graft.
One such polymer is poly(ether ether ketone) (PEEK)
(Fig. 1a). PEEK is a high strength, high performance aro-
matic thermoplastic polymer that is widely considered to
cause no detrimental biological response when im-
planted in the body and is resistant to both hydrolytic
and oxidative degradation mechanisms at temperatures
far exceeding that required for medical materials within
the body [24, 25]. It is utilised widely for load bearing
and high-wear resistant medical devices such as spinal
implants and acetabular cups [25, 26]. Availability of
powdered PEEK means combination with CS powders is
a viable strategy for the fabrication of reinforced com-
posites that has not yet been reported. This work de-
scribes the production of a composite PEEK/CS material
through the combination of PEEK and CS powders prior
to hardening and consolidation of the PEEK phase
through heating. We describe how the addition of PEEK
in this manner modifies the degradation and mechanical
properties of the materials.
Methods
Standard fabrication of PEEK/CS cylinders
Double Ground Alpha Base Crystacal (calcium sulphate
hemihydrate, CSH) (CaSO4.0.5H2O) (Saint-Gobain For-
mula, France) and 150XF PEEK (Victrex, UK) powders
were combined with 0 wt%, 2.5 wt%, 20 wt%, 40 wt%
and 80 wt% PEEK by mass. Pastes of each mixture were
produced under manual stirring with distilled water ac-
quired from an arium® advance EDI pure water system
(Sartorius, Germany) at a powder:liquid (P:L) ratio of
0.85 g/mL, before being poured into a mold to create cy-
lindrical specimens of dimensions 12 mm × 6 mm. The
mold was then placed upon a Denstar-500 vibrating
plate (Denstar, South Korea) set at high frequency to re-
move air bubbles. After 10 min, the mold was trans-
ferred to an Incu-line incubator (VWR International,
UK) at 37°C. After 1 h, specimens were carefully re-
moved from the mold and heated at a ramp rate of 5 oC
and held at 380 oC for 2.5 h in a CWF 1300 furnace
(Carbolite, UK). Specimens were then stored in ambient
conditions.
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Volumetric shrinkage
Cylinder volume of PEEK/CS specimens (n = 3) before heat
treatment and following heat treatment was calculated
from geometric measurements and % difference deter-
mined through calculation (Additional file 1: Equation S1).
SEM
Secondary electron scanning electron microscopy (SEM)
images of the fracture surfaces were obtained using a
Sigma FE-SEM (Zeiss, Germany) operating at 15 kV
under vacuum. PEEK/CS specimens with fracture sur-
face exposed were secured firmly upon double adhesive
carbon tapes attached to aluminium stubs before and
gold coated under vacuum for 2 min using a K550X
sputter coater (Quorum Technologies, UK) before im-
ages were acquired.
FT-IR spectroscopy
Fourier transform infrared spectroscopy between 500 cm
−1 and 4000 cm−1 was undertaken using a Nicolet 380
FT-IR spectrometer (Thermo-Scientific, USA). For sam-
ple preparation, 2 mg starting powders and powdered
PEEK/CS specimens were mixed with 198 mg KBr
(99.99% trace metals basis, Sigma-Aldrich, UK) and
pressed into 13 mm diameter discs using a evacuable
pellet die (Specac, UK) under a 10 ton force for 30 s
with a hydraulic press (Specac, UK).
Dynamic ageing protocol
Ageing was undertaken on n = 33 specimens per compos-
ition prepared as standard, with a further n = 10 specimens
per composition not subjected to ageing as a control group.
Individual PEEK/CS specimens were submerged in 10 mL
of calcium and magnesium free Dulbecco’s phosphate buff-
ered saline (PBS) solution (Sigma-Aldrich, UK) in screw
cap 60 mL capacity clear vessels. For a fixed set of n = 3
specimens, a daily record of PBS supernatant pH value, wet
mass, dry mass, wet height, dry height, wet mid-diameter,
dry mid-diameter, wet end-diameter and dry end-diameter
was recorded. Supernatant pH values were measured using
a S220 SevenCompact™ pH/Ion meter (Mettler Toledo,
USA) equipped with InLab Expert Pro-ISM pH electrode
(Mettler Toledo, USA). PBS supernatant was drained from
every specimen vessel and replenished with a further 10
mL. At 7 day intervals, n = 10 specimens per composition
were removed from the ageing protocol until day 21.
XRD
Powder X-ray diffraction (XRD) patterns were acquired
using a D8 Autosampler Powder Diffractometer (Bruker,
USA) with Cu Kα line (0.154 nm). Data was collected
between 5 o and 60 o 2θ with a 0.02 o step-size and a
step time of 0.5 s/o. Background signal was removed and
intensity normalised for each scan. Patterns were
matched to those stored by the International Centre for
Diffraction Data (ICDD) database.
Porosity
Apparent specimen density was calculated from geomet-
rical measurements of n = 10 heat-treated PEEK/CS speci-
mens before and during ageing. True specimen density
was obtained for the same specimens using an AccuPyc II
1340 helium pycnometer (Micrometrics, USA) over 5 cy-
cles of 5 purges. The relative density and porosity were
then calculated (Additional file 1: Equation S2 and S3).
Mechanical testing
Prior to mechanical testing, geometrical measurements
of PEEK/CS specimen diameter and height were made
to allow for calculations of contact area and test start
height. Compression tests were undertaken on n = 10
specimens per composition with their long-axis perpen-
dicular to the compression platen using a Z030 universal
testing rig (Zwick/Roell, USA) equipped with a 50 kN
Fig. 1 (a) Chemical structure of the poly(ether ether ketone) repeat monomer unit. (b) PEEK/CS specimens post heat treatment (Scale bar is equal
to 10 mm). (c) Volumetric shrinkage of PEEK/CS specimens due to heat treatment. Error bars represent standard deviation (n = 3) and lines above
data columns represent significant differences between groups based on PEEK wt% loading as found by post-hoc Turkey HSD tests following
one-way ANOVA analysis
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load cell at a compression rate of 2 mm/min until speci-
men failure. Compressive strength values were deter-
mined by converting values of force into stress and
plotting stress vs. strain curves from which the maximum
value of stress corresponding to specimen failure could be
obtained (Additional file 1: Equations S4 and S5, Figure
S1). Compressive modulus was determined by obtaining
the slope of the aforementioned curves within the elastic
region (Additional file 1: Equation S6, Figure S1).
Statistical analysis
Statistical analysis of data sets was conducted using Stat-
Plus software. One-way ANOVA and post-hoc Turkey
honest significant difference (HSD) testing was applied
to compare volumetric shrinkage of specimens after heat
treatment based on PEEK wt% loading. Two-way
ANOVA and post-hoc Turkey HSD testing was applied
to compare mechanical data of specimens based on
PEEK wt% loading and ageing time. Differences were
deemed significant if p < 0.05.
Results and discussion
Physical and chemical assessment of PEEK/CS cylinders
Following addition of water to starting powders a paste
was formed, which hardened to form the composite ma-
terial in accordance with Equation 1. Prior to heat treat-
ment, cylindrical specimens of each composition
appeared almost identical up to the point of heat treat-
ment (Fig. 1b). Heat treatment of PEEK/CS specimens
initiated melting of PEEK and dehydration of CSD
(CaSO4.2H2O) to CSA (CaSO4) (Equation 4). These
changes resulted in an alteration in both colour and
apparent volume. Starting powders of both CSH
(CaSO4.0.5H2O) and PEEK were both cream in colour-
ation. Specimens containing no PEEK (0% PEEK/
100%CS) remained similar in appearance after heat
treatment. Specimens of 2.5%PEEKCS acquired brown
speckles but still retained some cream colouration. Spec-
imens of 20%PEEK/80%CS and 40%PEEK/60%CS be-
came fully brown, whilst specimens of 80%PEEK/20%CS
became dark brown. Although the recommended pro-
cessing temperature for PEEK of 380 oC was employed,
polymer chain degradation can still occur leading to dis-
coloration, which was evidently more extensive with
greater loadings of PEEK (Fig. 1b).
Volumetric shrinkage of specimens also occurred as a
consequence of heat treatment (Fig. 1c). Specimens with
PEEK loading between 0 wt% and 40 wt% underwent a
volumetric shrinkage of between approximately 9% and
15%. Specimens of 80%PEEK/20%CS however appeared
significantly smaller and were confirmed to undergo the
greatest extent volumetric shrinkage of 39.7 ± 0.7%.
One-way ANOVA analysis confirmed that significant
differences in volumetric shrinkage existed between
groups based on PEEK wt% loading (F(4,10) = 87.3, p =
9.8x10−8). Post-hoc analysis utilising Turkey HSD tests
found no significant differences between groups with
PEEK loading between 0 wt% and 40 wt% (p > 0.05),
however significant differences did exist between these
groups and that of specimens loaded with 80 wt% PEEK
(p < 0.001). It is recommended that fractions of CS < 40
wt% are required to maintain volumetric structure that
undergoes no significant geometrical changes as a result
of melting PEEK compared to unreinforced material.
Fracture surfaces of a 20%PEEK/80%CS specimen
showed good dispersion of globular PEEK particles
(approximately 5 μm to 10 μm) situated within a dense
network of needles with high aspect ratio (approximately
20 μm by 2 μm) typical of the reported morphology for
CSD (CaSO4.2H2O) (Fig. 2a). Following heat treatment,
there was a change to a more flake-like morphology in
addition to needles (Fig. 2b). The powdered polymeric
particles were no longer apparent, since the PEEK phase
had fully melted and integrated with CS crystals.
FT-IR spectra of PEEK contained peaks indicative of
the chemical moieties present in its chemical structure
(Figs. 1a and 2c), including aromatic and carbonyl
groups [27–30]. Peaks associated with aromatic groups
are located at 3072 cm−1 and 3034 cm−1 representative
of = C-H stretching, and at 1592 cm−1 and 1486 cm−1
due to C = C stretching. Additional peaks at 850 cm−1
and 832 cm−1 are indicative of ring deformation vibra-
tional modes. Peaks corresponding to carbonyl groups
are found at 1652 cm−1, 1647 cm−1 and 1257 cm−1. Due
to peak overlap at 1652cm−1 and 1647cm−1, separate
bands are hard to distinguish, but indicates carbonyl
stretching in amorphous and crystalline regions of PEEK
respectively.
Vibrational modes of the SO4
2− anion within CSH
(CaSO4.0.5H2O) were identified on the corresponding
FT-IR spectrum [31–33] (Fig. 2c). A peak at approxi-
mately 1010 cm−1 can be assigned to SO3
2− symmetric
stretching. Peaks at 1114 cm−1 and 1080 cm−1 are as-
signable to SO4
2− anti-symmetric stretching, whilst peaks
at 658 cm−1 and 596 cm−1 are present due to SO4
2− anti-
symmetric bending. Peaks relating to O-H stretching
can be found between 3000 cm−1 and 3800 cm−1; peaks
in the spectrum of CaSO4.0.5H2O are located at 3603
cm−1 and 3551 cm−1. A singular O-H vibrational band is
also present at 1620 cm−1, indicative of CSH
(CaSO4.0.5H2O) hydration degree.
Vibrational bands relating to both PEEK and SO4
2− an-
ions are present in the spectrum of 20%PEEK/80%CS.
The symmetric stretching peak of SO4
2− remains located
at approximately 1010 cm−1, consistent with spectra of
both CSA (CaSO4) and CSH (CaSO4.0.5H2O). Substan-
tial reduction of O-H stretching peak intensity between
3000 cm−1 and 3800 cm−1 indicates dehydration of CS
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phase as expected (Equation 4). The singular O-H vibra-
tional band found at 1620 cm−1 in the spectrum of CSH
(CaSO4.0.5H2O) is no longer visible and is instead over-
lapped by peaks indicative of C = C stretching (1592 cm−1)
and carbonyl stretching (1652 and 1647 cm−1) of PEEK
polymer chains. Shaping of antisymmetric SO4
2− bending
modes between 550 cm−1 and 750 cm−1, consisting of 4
overlapping bands (591 cm−1, 612 cm−1, 667 cm−1 and
671 cm−1) suggests a mixture of CSA (CaSO4) and CSH
(CaSO4.0.5H2O). Peaks previously assigned within the FT-
IR spectrum of PEEK are visible in the spectrum of
20%PEEK/80%CS including ring deformation peaks at 850
cm−1 and 832 cm−1, the C = C stretching peak at 1592 cm
−1 and carbonyl stretching peaks 1652 cm−1 and 1647 cm
−1 appeared at a relatively lower intensity, compared to in
the spectrum of PEEK starting powder (Fig. 2c). Unex-
pectedly, this suggests PEEK is able to interact with CSA
(CaSO4) not only physically, but also chemically through
highly electron rich regions of PEEK polymer, including
aromatic rings and carbonyl groups.
Characterisation of dynamically aged PEEK/CS specimens
Fracture surfaces of 20%PEEK/80%CS specimens after
ageing in PBS undergo extensive microstructural trans-
formations (Fig. 3a-c). Ageing promotes development of
plate like crystal structures that are visible at Day 7 on-
wards, indicative of newly forming crystalline phases.
This may be due to the hydrating environment provided
by PBS media, promoting CS conversion from CSA
(CaSO4) to CSD (CaSO4.2H2O) (Equation 2). Crystal
structures are surrounded by a polymeric network of
PEEK, distinguished by non-crystalline material interact-
ing with crystal structures through both direct contact
and coating.
Powder XRD patterns were acquired in order to assess
CS phase changes as a consequence of ageing (Fig. 3d). The
powder XRD pattern for PEEK consisted of broad peaks in
keeping with PEEK’s semi-crystalline nature. Peaks located
at 2θ values of 19 o, 21 o, 23 o and 29 o are in-keeping with
those reported in the literature for PEEK [30]. Sharp and
narrow peaks within CSH (CaSO4.0.5H2O) pattern
indicated a crystalline material that matched to ICDD pat-
tern 01-081-1448. Following heat treatment, the corre-
sponding powder XRD pattern of a 20%PEEK/80%CS
specimen contained peaks corresponding to both PEEK
and CS phase components, namely CSA (CaSO4) and CSH
(CaSO4.0.5H2O) matching ICDD patterns 01-070-0909 and
01-081-1448 respectively. After 7, 14 and 21 days of ageing,
powder XRD patterns of 20%PEEK/80%CS specimens pos-
sessed peaks corresponding to CSD (CaSO4.2H2O), which
were matched to ICDD pattern 00-033-0311, in addition to
peaks corresponding to PEEK.
Submergence of heat treated PEEK/CS specimens in
PBS media initiated an immediate degradation state in
specimens loaded with 0% and 2.5% PEEK, however a low
loading level of 2.5%, PEEK increased calcium CS longev-
ity overall; complete deterioration of 2.5%PEEK/97.5%CS
specimens did not occur until day 17 (Additional file 1:
Figure S2). Mass remaining profiles calculated from dry
measurements showed consistent day to day mass loss
with regards to 0%PEEK/100%CS and 2.5%PEEK/97.5%CS
specimens, equivalent to degradation rates of 14.1%/day of
Fig. 2 SEM micrographs of a fracture surface of a 20%PEEK/80%CS
specimen prepared at a P:L ratio of 0.85 g/mL (a) prior to heat
treatment and (b) after heat treatment. (c) FT-IR spectra between
500 cm−1 and 4000 cm−1 wavenumbers of PEEK and CSH
(CaSO4.0.5H2O) starting powders, and a powdered 20%PEEK/80%CS
specimen after heat treatment
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ageing (r2 = 0.99) and 7.9%/day of ageing (r2 = 0.97) re-
spectively. This resulted in 16.9 ± 5.4% mass remaining
after 6 days and 25.4 ± 15.5% mass remaining after 9 days
of unreinforced PEEK/CS specimens and 2.5 wt% PEEK
loaded specimens respectively (Fig. 4a). In contrast,
20%PEEK/80%CS and 40%PEEK/60%CS specimens in-
creased in mass up to 17.6 ± 1.9% and 9.7 ± 1.8% respect-
ively over the course of ageing duration (Fig. 4a).
Deterioration of 20%PEEK/80%CS, of 40%PEEK/60%CS
and 80%PEEK/20%CS specimens was not evident at any
stage of ageing, due to increased physical and chemical in-
teractions between PEEK and CS (Additional file 1: Figure
S2). Interestingly, PEEK reinfrocement was shown to fa-
cilitate CS phase change from CSA (CaSO4) and CSH
(CaSO4.0.5H2O) to CSD (CaSO4.2H2O) leading to a mass
increase (Equation 1 and 2) (Figs. 3d and 4a). Theoretic-
ally, from known mass of CSA (CaSO4) consistuting each
composite composition, calculations of maximum mass
increase due to crystal hydration were 21.2% for
20%PEEK/80%CS and 15.8% for 40%PEEK/60%CS speci-
mens, which is consistent with observed increases of 17.6
± 1.9% and 9.7 ± 1.8% respectively. Mass changes experi-
enced by 80%PEEK/20%CS specimens were found to be
negligible, and never deviated by more than 0.5% either
side of 100% of original specimen mass (Fig. 4a). Simul-
taneously, between 5% to 10% decreases in porosity were
measured for 20%PEEK/80%CS, 40%PEEK/60%CS and
80%PEEK/20%CS specimens after 21 days ageing (Table 1),
possibly arising from crystal hydration of CS and a de-
crease in microstructure free volume.
PEEK/CS specimen mass was consistently greater with
regards to wet measurements compared to dry measure-
ments (Fig. 4b,c). Specimens of 0%PEEK/100%CS and
2.5%PEEK/97.5%CS experienced daily increases in mass
averaging 81.3 ± 9.4% over 6 days and 88.8 ± 10.1% over
9 days of ageing respectively (Fig. 4d). Specimens of
Fig. 3 SEM images of 20%PEEK/80%CS specimens after ageing in PBS media for (a) 7 Days, (b) 14 Days and (c) 21 Days. (d) XRD diffraction
patterns between 2θ values of 5 o and 60 o of PEEK and CSH (CaSO4.0.5H2O) starting powders, and powdered 20%PEEK/80%CS specimens after
heat treatment prior to ageing (0 Days), and after 7 Days, 14 Days and 21 Days of ageing. An XRD pattern for PEEK from the literature confirmed
the crystal structure of the polymer (•, see [30]). ICDD patterns matching CSH (CaSO4.0.5H2O) (, ICDD pattern 01-081-1448), CSA (CaSO4) (, ICDD
pattern 01-070-0909) and CSD (CaSO4.2H2O) (, ICDD pattern 00-033-0311) (CaSO4.0.5H2O, CaSO4 and CaSO4.2H2O phases respectively) are also
provided to aid in CS phase identification
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20%PEEK/80%CS, 40%PEEK/60%CS and 80%PEEK/
20%CS experienced lower average daily increases in
mass of 35.7 ± 1.3%, 42.4 ± 2.8% and 30.8 ± 3.8% respect-
ively over 21 days of ageing (Fig. 4d). Nonetheless, this
was considered as a reflection of absorptive capability
and porous nature of PEEK/CS specimens, as PEEK/CS
specimen height, mid-diameter and end-diameter
showed no substantial differences between wet and dry
measurements (Fig. 5a-f ). Exploitation of absorbance
capacity in situ may facilitate localisation of nutrients
from adjacent tissues beneficial to osteoblast viability
[34]. A feasible avenue of further investigation may be
the loading of soluble therapeutics through liquid ex-
change with PEEK/CS materials to aid bone regeneration
[35, 36]. Specimens of 0%PEEK/100%CS and 2.5%PEEK/
97.5%CS experienced substantial losses to cylindrical di-
mensions in terms of height and both mid-diameter and
end-diameter.
Direct measurements of PBS pH were indicative of ma-
terial degradation (Fig. 6) (Additional file 1: Figure S2).
Specimens of 0%PEEK/100%CS and 2.5%PEEK/97.5%CS
lowered PBS pH from 7.4 to between 5 and 6. Such an
environment can beneficially demineralise adjacent bone,
in-turn releasing growth factors (i.e. bone morphogenic
protein) that contribute to mesenchymal cell differentiation
into osteoblasts, which may encourage the deposition of
new bone [37, 38]. However, rapid 0%PEEK/100%CS and
2.5%PEEK/97.5%CS degradation before bone formation can
occur would be a significant concern that would limit the
application of these particular compositions of composite.
With regards to 0%PEEK/100%CS and 2.5%PEEK/97.5%CS,
the pH value of supernatant was found to decrease less ex-
tensively on a daily basis in accordance with the reducing
Fig. 4 (a) PEEK/CS specimen mass remaining expressed as percentage (%) calculated from dry measurements. (b) Changes in PEEK/CS specimen
mass measured dry and (c) wet. (d) PEEK/CS specimen mass increase expressed as a percentage (%) calculated between difference in dry and
wet mass measurements. Error bars represent standard deviation (n = 3)
Table 1 Porosity (%) of PEEK/CS specimens after heat treatment





0 2.5 20 40 80
0 70.7 ± 3.15 72.1 ± 0.49 73.9 ± 1.3 73.5 ± 1.6 54.6 ± 3.4
7 - - 65.8 ± 2.4 67.7 ± 1.4 52.0 ± 3.9
14 - - 68.0 ± 1.0 68.2 ± 2.9 50.0 ± 2.8
21 - - 65.9 ± 1.7 66.5 ± 1.4 49.7 ± 3.7
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mass of specimens due to dissolution of CS content and re-
plenishment of PBS media (Figs. 4a-c and 6) (Additional file
1: Figure S2). Specimens of 20%PEEK/80%CS, 40%PEEK/
60%CS and 80%PEEK/20%CS had little affect on pH of PBS
ageing supernatant as values remained close to neutral
throughout ageing (Fig. 6) (Additional file 1: Figure S2).
Mechanical properties of PEEK/CS specimens
The compressive strength and modulus of CS (typically
hydrated CSD (CaSO4.2H2O)) is typically in the range of
10 MPa to 20 MPa and between 3 GPa and 6 GPa respect-
ively when prepared at P:L ratios between 1.5 g/mL and 2
g/mL [39, 40]. Critically, the mechanical properties of CS
in this study were several orders of magnitude lower,
resulting in compressive strength of 1.2 ± 0.3 MPa and
compressive modulus of 0.084 ± 0.1 GPa. Preparation of
pastes at P:L ratio of 0.85 g/mL (greater volume liquid
fraction) evidently introduces porosity and areas of poor
resistance to stress (Table 1). Further optimization of the
composite may be enabled by increasing P:L ratio during
Fig. 5 (a) Changes in PEEK/CS specimen height measured dry and (b) wet. (c) Changes in PEEK/CS specimen mid-diameter measured dry and (d)
wet. (e) Changes in PEEK/CS specimens end-diameter measured dry and (f) wet. Error bars represent standard deviation (n = 3)
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PEEK/CS fabrication [41]. Furthermore, compressing
specimens prior to heat treatment, and preparing pastes
under vacuum may both lower the relatively high porosity
of structures prior to ageing and provide additional mech-
anical stability during exposure to in vitro physiological
conditions [42, 43].
Importantly, our findings show PEEK in able to bring
about significant gains in CS composite compressive
strength based on PEEK wt% loading (Fig. 7a). Specimens
of 20%PEEK/80%CS and 40%PEEK/60%CS provided ap-
proximately 3-fold and 4-fold increases in compressive
strength respectively prior to ageing. Interestingly, 80 wt%
PEEK loading provides a further substantial rise in
compressive strength of 26.6 ± 3.9 MPa prior to ageing,
equating to an approximate 22-fold gain. A significant in-
crease was not found between groups of specimens based
on ageing time (F(3,12) = 2.1, p = 0.16), indicating speci-
mens did not weaken notably due to prolonged submer-
gence in PBS media in terms of compressive strength.
Promisingly, ageing did not significantly alter compressive
strength of specimens over 21 days (Fig. 7a). Despite this,
compressive modulus generally decreased with ageing time
(Fig. 7b). Evidently, a complex relationship exists between
the physical and chemical interactions of PEEK with CS,
such that mechanical reinforcement is provided but not ne-
cessarily maintained during facilitation of CS phase evolu-
tion and corresponding microstructural transformations.
Mechanism of PEEK reinforcement of CS
We propose that the strengthening and subsequent aug-
mentation of degradation behaviour of PEEK/CS com-
posites is due to enhanced interactions between CS
crystals from the physical and chemical intercalation of
PEEK following heat treatment. Without PEEK, CS is
unable to retain its structure during microstructural and
phase transitions initiated by PBS media. 0%PEEK/
100%CS specimens likely fall apart from the infiltration
of PBS solution that initiates dissolution. Heating the
composites containing PEEK allows the polymer content
to coat the CS crystal matrix. Even at low loadings of
PEEK, such as 2.5 wt%, composites demonstrate
enhanced strength and degradation response when com-
pared to 0%PEEK/100%CS. However, the further physio-
chemical improvements observed at PEEK loadings of at
least 20 wt% suggests that at these levels the polymer
phase is able to infiltrate the entirety of structures and
form a polymeric reinforcing network that binds to crys-
talline structures. As PEEK does not deteriorate in
Fig. 6 Direct pH measurements of PEEK/CS specimen PBS ageing
supernatant before replenishment. PBS has a pH 7.4, and is shown in
the figure by a purple dashed line as indicated by the legend. Error
bars represent standard deviation (n = 3)
Fig. 7 (a) Compressive strength and (b) Compressive modulus of PEEK/CS specimens after heat treatment and during ageing. Bar colouration is
representative of ageing time as indicated by the legend. Error bars represent standard deviation (n = 10) and lines above data columns represent
significant differences between groups based on PEEK wt% loading as found by post-hoc Turkey HSD tests following two-way ANOVA analysis
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hydrolytic environments, the PEEK network retains struc-
tural dimensions of composites whilst protecting CS crys-
tals from rapid deterioration in PBS media. Additionally,
PEEK facilitates microstructural and compositional phase
conversion of CS material from CSA (CaSO4) to CSD
(CaSO4.2H2O) (Equation 2), which suggests that some CS
crystals remain exposed to PBS. Positively therefore, bone-
forming cells may still utilise the resorbable CS content
available within PEEK/CS composite materials as an
osteogenic scaffold for bone deposition.
Conclusions
Acquisition of physical interactions between PEEK and CS
was achieved by heating of PEEK/CS specimens. Conse-
quentially, this led to specimen discoloration regarding
specimens that contained PEEK, as well as volumetric
shrinkage. Excitingly however, evidence of chemical inter-
actions between PEEK with CS through aromatic and car-
bonyl moieties of the polymer chain were found to exist.
The nature of these interactions significantly enhances in
vitro dissolution behavior and physical attributes. As such,
PEEK can be utilised to fundamentally improve CS attri-
butes directly relevant to bone graft requirements, espe-
cially considering large defect volumes that require a
protracted presence of osteogenic scaffold and mechanical
stability.
Additional file
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